The Dissociation of α2-Plasmin-Inhibitor-Plasmin Complex to Active Plasmin by SDS Treatment

  • Dong Yan
  • Tetsumei Urano
  • Yumiko Takada
  • Akikazu Takada
Conference paper


α2-PI has been demonstrated to be the physiologically most important inhibitor to plas. sin in plasma [1–3], it is a single-chain glycoprotein with molecular weight of about 68,000 [2,4] and inhibits proteolytic activity of plasmin by forming a 1:1 stoichiometric complex which is enzymatically inactive and hardly dissociated by dodecyl sulfate under reducing conditions [5]. α2-PI has been classified as a member of the serine protease inhibitor super family (SERPINS) [6] to which plasminogen activator inhibitor type 1 (PAI-1) also belongs. These protease inhibitors have many similar points in their ways to react with their target enzymes. It has been reported that the complex between PAI-1 and tissue plasminogen activator (t-PA) shows enzymatic activity in zymography [7]. Recently it was also shown that PAI-1 lost its inhibitory activity and was cleaved at the reactive site by PAs after SDS treatment [8]. The latter phenomenon may be responsible for tPA-PAI-1 complex to express enzymatic activity in zymography [8]. Since both PAI-1 and α2-PI are members of SERPINS, it is naturally considered whether SDS has similar effects on α2-PI molecule. We, therefore, investigated the effect of SDS on both α2-PI and α2-PI-plasmin complex in the present study. We also discuss the possible mechanism for α2-PI-plasmin complex to possess enzymatic activity in zymography.


Plasminogen Activator Coomassie Blue Staining High Molecular Weight Complex Amidolytic Activity Active Site Serine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Collen D (1976) Eur J Biochem 69: 209–216PubMedCrossRefGoogle Scholar
  2. 2.
    Moroi M, Aoki N (1976) J Biol Chem 251: 5956–5965PubMedGoogle Scholar
  3. 3.
    Müllertz S, Clemmensen I (1976) Biochem J 159: 545–553PubMedGoogle Scholar
  4. 4.
    Wiman B, Collen D (1977) Eur J Biochem 78: 19–26PubMedCrossRefGoogle Scholar
  5. 5.
    Wiman B, Collen D (1979) J Biol Chem 254: 9291–9297PubMedGoogle Scholar
  6. 6.
    Carrell R (1984) Nature 312: 14PubMedCrossRefGoogle Scholar
  7. 7.
    Takada Y, Takada A (1991) Thrombosis Research 63: 169–177PubMedCrossRefGoogle Scholar
  8. 8.
    Urano T, Strandberg L, Johansson B-AL, Ny T (1992) Eur J Biochem in press.Google Scholar
  9. 9.
    Wiman B (1980) Biochem J 191: 229–232PubMedGoogle Scholar
  10. 10.
    Jameson GW, Roberts DV, Adams RW, Kyle WSA, Elmore DT (1973) Biochem J 131: 107–117PubMedGoogle Scholar
  11. 11.
    Laemmli KU (1970) Nature 227: 680–685PubMedCrossRefGoogle Scholar
  12. 12.
    Granelli-piperno A, Reich M (1978) J Exp Med 148: 223–234CrossRefGoogle Scholar
  13. 13.
    Christensen U, Clemmensen I (1977) Biochem J 163: 389–391PubMedGoogle Scholar
  14. 14.
    Wiman B, Collen D (1978) Eur J Biochem 84: 573–578PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 1993

Authors and Affiliations

  • Dong Yan
    • 1
  • Tetsumei Urano
    • 1
  • Yumiko Takada
    • 1
  • Akikazu Takada
    • 1
  1. 1.Department of PhysiologyHamamatsu University, School of MedicineHamamatsu-shi, Shizuoka-kenJapan

Personalised recommendations